HYPR
Hyperfine, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.78
+1.54%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$0.78
From 52W high−64.33%
Volume547049.00
Market cap$83.22M
P/E (TTM)—
P/S (TTM)5.0x
Div yield—
Key dataSep 18, 2026
Open
$0.78
From 52W high
−64.33%
Volume
547049.00
Market cap
$83.22M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.6x
P/E (TTM)
—
RSI (14)
32.4
MomentumView details →
1D Return
+1.54%
YTD Return
−20.48%
SummaryUpdated Jun 1, 2026
Hyperfine, Inc. (NASDAQ:HYPR) is a medical device company founded in 2014 and based in Guilford, Connecticut. The company went public in January 2021 through a SPAC merger. Hyperfine develops and commercializes portable magnetic resonance imaging (MRI) technology, with its flagship product being the Swoop Portable MR imaging system. The company represents a pioneering effort to make MRI technology more accessible by creating a portable, point-of-care solution that can be deployed in various healthcare settings beyond traditional hospital radiology departments.
Similar companies
Latest newsMore news →
Hyperfine, Inc. received a Nasdaq notice dated September 17, 2026 that its common stock failed to maintain the minimum $1.00 bid price required by Nasdaq Listing Rule 5450(a)(1), giving it until March 16, 2027 to regain compliance.2d agoMedtechWOMEN named Maria Sainz, President and CEO of Hyperfine, Inc., the winner of its 2026 Ferolyn Powell Leadership Award, and Beverly Tang, co-founder and CEO of Starlight Cardiovascular, the recipient of its first-ever Rising Star Award, at the MedtechVISION Annual Conference in Menlo Park, California.4d ago